CFO Moves this week include:
| Echo Therapeutics, Inc. |
Would you like to receive our weekly CFO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any CFO Moves to report, please email us.
CFO Moves is published by Samuel Dergel (Executive Search Consultant and CFO & Financial Executive Search Specialist with Stanton Chase International). Samuel can be reached by email at s.dergel@stantonchase.com or by phone at +1 (415) 738-2070.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Echo Therapeutics, Inc. (NASDAQ: ECTE) announced that Alan W. Schoenbart joined the Company as Chief Financial Officer. Mr. Schoenbart joins Echo from Hudson News Distributors, LLC where he most recently served as CFO. Prior to that, Mr. Schoenbart served as the CFO for Forticell Bioscience, Inc. Mr. Schoenbart has also held prior CFO positions at Vizacom Inc., and Windswept Environmental Group, Inc. Prior to that, he was an audit manager at KPMG LLP.
